Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 14/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4771035 | 0.90 | GPR119 (0.47) | GPR119BACE1KDM4EPKMFAAH | |
| SCHEMBL4773835 | 0.90 | KDM4E (0.46) | GPR119BACE1KDM4EPKMFAAH | |
| SCHEMBL4775404 | 0.76 | GPR119 (0.51) | GPR119BACE1KDM4EPKMFAAH | |
| SCHEMBL4771557 | 0.76 | BACE1 (0.51) | GPR119BACE1KDM4EPKMFAAH | |
| SCHEMBL190831 | 0.74 | GPR119 (0.49) | GPR119BACE1KDM4EPKMFAAH | |
| SCHEMBL4777857 | 0.74 | FAAH (0.47) | GPR119BACE1KDM4EPKMFAAH | |
| SCHEMBL12255478 | 0.73 | FAAH (0.50) | GPR119BACE1KDM4EPKMFAAH | |
| SCHEMBL7551259 | 0.72 | LMNA (0.46) | GPR119 | |
| SCHEMBL13645880 | 0.70 | GPR119 (0.46) | GPR119BACE1KDM4E | |
| SCHEMBL15645613 | 0.69 | BACE1 (0.48) | GPR119BACE1KDM4EPKMFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1220842-A1 | CYCLIC AMINE COMPOUNDS AS CCR5 ANTAGONISTS | Takeda Chemical Industries, Ltd. (JP) | 2002-07-10 | — | — | EP | disclosed |
| WO-2001025200-A1 | CYCLIC AMINE COMPOUNDS AS CCR5 ANTAGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-04-12 | — | — | WO | disclosed |